XML 26 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Cash Flows From Operating Activities:    
Net income (loss) $ (3,286,804) $ (3,672,891)
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:    
Depreciation and amortization 885,843 895,990
Loss on mineral properties 318,502 1,410,736
Write-down of inventory to net realizable value 0 16,396
Amortization of debt discount 0 54,112
Accretion of asset retirement obligation 7,851 6,148
Common stock issued for services 0 136,000
Common stock payable for directors fees 106,108 134,375
Non-cash miscellaneous income (660) (598)
Change in:    
Accounts receivable 45,819 153,938
Inventories (23,969) 112,621
IVA receivable and other assets (38,361) 199,337
Accounts payable (452,103) 402,657
Accrued liabilities (2,662) 76,416
Export tax assessment payable 1,120,730 0
Payables to related parties 14,042 63,408
Net cash provided (used) by operating activities (1,305,664) (11,355)
Cash Flows From Investing Activities:    
Payment received on note receivable for sale of land 0 400,000
Purchase of properties, plants and equipment (243,091) (792,925)
Net cash provided (used) by investing activities (243,091) (392,925)
Cash Flows From Financing Activities:    
Change in checks issued and payable 69,052 (28,849)
Proceeds from issuance of common stock and warrants, net of issuance costs 1,813,068 404,199
Advances from related party 0 237,400
Payments on advances from related party (83,419) (35,066)
Proceeds from CARES Act Note Payable 443,400 0
Proceeds (payments) on notes payable to bank, net (97,066) 13,149
Principal payments of long-term debt (46,670) (127,683)
Net cash provided (used) by financing activities 2,098,365 463,150
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH 549,610 58,870
Cash and cash equivalents at beginning of year 172,767 113,897
Cash and cash equivalents at end of year 722,377 172,767
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Interest paid in cash 17,991 24,233
Noncash investing and financing activities:    
Common stock payable issued to directors 130,483 175,000
Payable to related party satisfied with exercise of stock purchase warrant $ 62,500 $ 0